Evidence map›Paper›PMID 30520052›Full record

ArticleHepatology (Baltimore, Md.)2019

Hepatic Autophagy Deficiency Compromises Farnesoid X Receptor Functionality and Causes Cholestatic Injury.

Bilon Khambu, Tiangang Li, Shengmin Yan, Changshun Yu, Xiaoyun Chen, Michael Goheen, Yong Li, Jingmei Lin, Oscar W Cummings, Youngmin A Lee and 5 more

Open access · greenAbstract read
In one paragraph

Article in Hepatology (Baltimore, Md.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Knockout of farnesoid X receptor gene aggravates cisplatin-induced kidney injury.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2022
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 2 countries.

Bilon KhambuDepartment of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN.
Tiangang LiDepartment of Pharmacology, Toxicology and Therapeutics, The University of Kansas, Medical Center, Kansas City, KS.
Shengmin YanDepartment of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN.
Changshun YuDepartment of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN.
Xiaoyun ChenDepartment of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN.
Michael GoheenDepartment of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN.
Yong LiDepartment of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN.
Jingmei LinDepartment of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN.
Oscar W CummingsDepartment of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN.
Youngmin A LeeDepartment of Medicine, Mount Sinai Medical School, New York, NY.
Scott FriedmanDepartment of Medicine, Mount Sinai Medical School, New York, NY.
Zheng DongDepartment of Nephrology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Gen-Sheng FengDepartment of Pathology, University of California at San Diego, San Diego, CA.
Shangwei WuCenter of Pathology and Laboratory Medicine, Nankai Hospital, Tianjin, China.
Xiao-Ming YinDepartment of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN.ORCID 0000-0002-8576-6093
Indiana University School of MedicineGuangzhou Medical University · CNIndiana University – Purdue University Indianapolis · USMount Sinai Medical Center · USCentral South University · CNTianjin Nankai Hospital · CNUniversity of California, San Diego · USUniversity of Kansas Medical Center · US

Funding

The Southernearch Center for ALPD and CirrhosisP50AA011999 · NIAAA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ANNA S. GUKOVSKAYA · 1999 to 2026
$45.8M
Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational SuccessUL1TR001866 · NCATS · ROCKEFELLER UNIVERSITY · PI COLLER, BARRY, KRUEGER, JAMES G · 2016 to 2025
$40.6M
The Role of KLF6 in Hepatic FibrosisR01DK056621 · NIDDK · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI FRIEDMAN, SCOTT L. · 2000 to 2019
$6.2M
Regulation of Bile Acid Metabolism and Signaling in Metabolic DiseasesR01DK117965 · NIDDK · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Tiangang Li · 2019 to 2026
$2.7M
The dynamics and mechanisms of autophagy in ethanol - induced liver pathogenesisR01AA021751 · NIAAA · INDIANA UNIVERSITY INDIANAPOLIS · PI TSUKAMOTO, HIDEKAZU, YIN, XIAO-MING · 2013 to 2017
$2.1M
The Role of HMGB1 in autophagy deficiency-induced liver pathologyR01DK116605 · NIDDK · TULANE UNIVERSITY OF LOUISIANA · PI YIN, XIAO-MING · 2018 to 2021
$1.7M
The role of hepatic Sortlin 1 in diabetic dyslipidemiaR01DK102487 · NIDDK · UNIVERSITY OF KANSAS MEDICAL CENTER · PI LI, TIANGANG · 2014 to 2018
$1.6M
Mechanism and role of selective autophagy in ethanol-induced liver injuryR21AA021450 · NIAAA · INDIANA UNIVERSITY INDIANAPOLIS · PI YIN, XIAO-MING · 2014 to 2015
$332k
NCATS NIH HHS UL1 TR001866NIAAA NIH HHS P50 AA011999NIAAA NIH HHS R01 AA021751NIAAA NIH HHS R21 AA021450NIDDK NIH HHS R01 DK056621NIDDK NIH HHS R01 DK116605NIDDK NIH HHS R01 DK117965
6 · The paper itself

Abstract

Autophagy is important for hepatic homeostasis, nutrient regeneration, and organelle quality control. We investigated the mechanisms by which liver injury occurred in the absence of autophagy function. We found that mice deficient in autophagy because of the lack of autophagy-related gene 7 or autophagy-related gene 5, key autophagy-related genes, manifested intracellular cholestasis with increased levels of serum bile acids, a higher ratio of tauromuricholic acid/taurocholic acid in the bile, increased hepatic bile acid load, abnormal bile canaliculi, and altered expression of hepatic transporters. In determining the underlying mechanism, we found that autophagy sustained and promoted the basal and up-regulated expression of farnesoid X receptor (Fxr) in the fed and starved conditions, respectively. Consequently, expression of Fxr and its downstream genes, particularly bile salt export pump, and the binding of FXR to the promoter regions of these genes, were suppressed in autophagy-deficient livers. In addition, codeletion of nuclear factor erythroid 2-related factor 2 (Nrf2) in autophagy deficiency status reversed the FXR suppression. Furthermore, the cholestatic injury of autophagy-deficient livers was reversed by enhancement of FXR activity or expression, or by Nrf2 deletion. Conclusion: Together with earlier reports that FXR can suppress autophagy, our findings indicate that autophagy and FXR form a regulatory loop and deficiency of autophagy causes abnormal FXR functionality, leading to the development of intracellular cholestasis and liver injury.

Indexed as

AutophagyAnimalsBile Acids and SaltsCholestasis, IntrahepaticFemaleFood DeprivationLiverMaleMice, TransgenicNF-E2-Related Factor 2Receptor, Farnesoid X-ActivatedReceptors, Cytoplasmic and NuclearBile Acids and SaltsNfe2l2 protein, mouseNF-E2-Related Factor 2Receptor, Farnesoid X-ActivatedReceptors, Cytoplasmic and Nuclear

Identifiers

PMID30520052
PMCPMC6461497
OpenAlexW2904802960

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.